Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Patient and public involvement in cancer-associated thrombosis research: necessary or glorified tokenism?

Simon Noble

16-05-2024

https://doi.org/10.4081/btvb.2024.125

1163

PDF: 182
Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA)

Daniela Poli, Riccardo Tartaglia, Doris Barcellona , Paolo Bucciarelli , Antonio Ciampa, Elvira Grandone, Giuseppe Malcangi, Giuseppe Rescigno, Vincenzo Toschi, Sophie Testa, Alessandro Squizzato

21-03-2023

https://doi.org/10.4081/btvb.2023.59

540

PDF: 222
Restrained glycoprotein VI-induced platelet signaling by tyrosine protein phosphatases independent of phospholipase Cγ2

Jingnan Huang, Delia I. Fernández, Jinmi Zou, Xueqing Wang, Johan W.M. Heemskerk, Ángel García

11-10-2023

https://doi.org/10.4081/btvb.2023.93

388

PDF: 147
Plasma fibrinogen levels and all-cause and cause-specific mortality in an Italian adult population: results from the Moli-sani study

Roberta Parisi, Simona Costanzo, Romy de Laat-Kremers, Augusto Di Castelnuovo, Amalia De Curtis, Teresa Panzera, Mariarosaria Persichillo, Chiara Cerletti, Giovanni de Gaetano, Maria Benedetta Donati, Licia Iacoviello, Bas de Laat , for the Moli-sani Study Investigators

27-01-2023

https://doi.org/10.4081/btvb.2023.46

1576

PDF: 400

APPENDIX: 79
Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

Paolo Simioni, Vittorio Pengo, Paolo Prandoni

07-11-2022

https://doi.org/10.4081/btvb.2022.52

1981

PDF: 219
Circulating albumin-to-fibrinogen ratio may be a risk indicator for venous thromboembolism: findings from a population-based prospective cohort study

Setor K. Kunutsor, Sudhir Kurl, Ari Voutilainen, Jari Laukkanen

14-07-2022

https://doi.org/10.4081/btvb.2022.36

1027

PDF: 221
Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

Vittorio Pengo, Luca Sarti, Emilia Antonucci, Stefania Di Agostino, Elisa Bison, Gentian Denas, Daniela Poli, Pier Luigi Meroni, Roberto Gerli, Antonella Radice, Gualtiero Palareti, on behalf of FIRMA group and START collaborators

12-10-2023

https://doi.org/10.4081/btvb.2023.92

774

PDF: 219
Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis

Robert Parambi, Nicole Ziliotto, Francesco Bernardi , Marcello Baroni , Richard W Browne , Dejan Jakimovski, Bianca Weinstock-Guttman, Robert Zivadinov, Murali Ramanathan

17-10-2022

https://doi.org/10.4081/btvb.2022.41

2236

PDF: 237

Supplementary Files: 59
On the impact of generative artificial intelligence on peer review

Giovanni de Gaetano, Chiara Cerletti, Augusto Di Castelnuovo

03-03-2025

https://doi.org/10.4081/btvb.2025.176

664

PDF: 214
The Lefoulon Delalande Foundation honors the lymphatic vascular system

Anne Eichmann

26-10-2023

https://doi.org/10.4081/btvb.2023.99

2330

PDF: 193
Unveiling the “common soil” of cardiovascular disease and cancer

Licia Iacoviello, Maria Benedetta Donati

24-02-2025

https://doi.org/10.4081/btvb.2025.167

693

PDF: 188
Comparison among three different bleeding scores and the thrombin generation assay to assess the different hemorrhagic phenotypes in patients with FVII deficiency

Samantha Pasca, Cristina Santoro, Chiara Ambaglio, Marisanta Napolitano, Marta Milan, Letizia Natali, Silvia Nannizzi, Filippo Mori, Paolo Simioni, Ezio Zanon

23-05-2022

https://doi.org/10.4081/btvb.2022.12

4971

PDF: 301
A commitment to global collaboration, welcoming international participation and advancing science for the benefit of patients

Pantep Angchaisuksiri, Wolfram Ruf, Jeffrey Weitz, Sam Schulman, Guy A. Young

18-04-2025

https://doi.org/10.4081/btvb.2025.188

133

PDF: 36
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

Marco P. Donadini, Walter Ageno

15-04-2022

https://doi.org/10.4081/btvb.2022.22

2006

PDF: 528
Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

Ang Li, Emily Zhou

16-05-2024

https://doi.org/10.4081/btvb.2024.108

690

PDF: 266
Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial

Giovanni de Gaetano

29-10-2024

https://doi.org/10.4081/btvb.2024.156

1366

PDF: 262

Appendix: 186
Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

22-03-2022

https://doi.org/10.4081/btvb.2022.10

1042

PDF: 330

APPENDIX: 67
Blood platelets, prostaglandins and aspirin: a historical and personal rereading

Giovanni de Gaetano, Chiara Cerletti

13-03-2024

https://doi.org/10.4081/btvb.2024.121

1200

PDF: 207
Platelet distribution width is associated with cardiovascular mortality in an adult general population

Benedetta Izzi, Simona Costanzo, Alessandro Gialluisi, Amalia De Curtis, Sara Magnacca, Teresa Panzera, Augusto Di Castelnuovo, Maria Benedetta Donati, Chiara Cerletti, Marc F. Hoylaerts, Giovanni de Gaetano, Licia Iacoviello, *on behalf of the Moli-sani Study Investigators

27-09-2023

https://doi.org/10.4081/btvb.2023.83

1576

PDF: 267

Supplementary Material: 43
The use of creatine and the development of deep vein thrombosis. A scoping review

Kartik Akkihal, Thomas Varkey, James Kelbert

18-11-2024

https://doi.org/10.4081/btvb.2024.142

2746

PDF: 250

Supplementary: 97
Artificial intelligence and machine learning in hemostasis and thrombosis

Paolo Gresele

30-12-2023

https://doi.org/10.4081/btvb.2023.105

2349

PDF: 475
SISET50: trajectories of hemostasis and thrombosis in Italy 1970-2020

Giovanni de Gaetano, Maria Benedetta Donati, Americo Bonanni

17-01-2025

https://doi.org/10.4081/btvb.2025.170

947

PDF: 197
Antithrombotic therapy in idiopathic infertility

Fabio Tumminello, Silvia Cardi, Corrado Lodigiani, Maria Elisa Mancuso

03-10-2024

https://doi.org/10.4081/btvb.2024.126

1903

PDF: 434
Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma

Yishi Tan, Marc Carrier, Nicola Curry, Michael Desborough, Kathryn Musgrave, Marie Scully, Tzu-Fei Wang, Mari Thomas, Simon J. Stanworth

16-05-2024

https://doi.org/10.4081/btvb.2024.115

660

PDF: 209
Distal deep vein thrombosis: is there a way out of this dark forest?

Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini

04-09-2024

https://doi.org/10.4081/btvb.2024.129

692

PDF: 219
Author's Reply. Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial

Giovanni de Gaetano

05-12-2024

https://doi.org/10.4081/btvb.2024.163

533

PDF: 109
The night of randomized clinical trials where all patients are black: a need to estimate variability in treatment effects

Giovanni de Gaetano, Chiara Cerletti, Licia Iacoviello, Maria Benedetta Donati

22-03-2022

https://doi.org/10.4081/btvb.2022.24

1775

PDF: 252
Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares

16-05-2024

https://doi.org/10.4081/btvb.2024.114

480

PDF: 178
Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled trial"

Vittorio Pengo

16-04-2025

https://doi.org/10.4081/btvb.2025.179

145

PDF: 41
It’s definitely time to consider diet in its ultra-processing form as a major risk factor for thrombotic vascular disorders

Marialaura Bonaccio, Licia Iacoviello, Maria Benedetta Donati

03-08-2023

https://doi.org/10.4081/btvb.2023.91

1100

PDF: 212
The 2024 Nobel prize in Medicine: impact on hemostasis and thrombosis research

Loredana Bury, Marco Malvestiti, Paolo Gresele

19-11-2024

https://doi.org/10.4081/btvb.2024.159

914

PDF: 216
2024 EACTS guidelines on perioperative medication in adult cardiac surgery: embracing precision medicine driven by strong evidence-based methodology

Bianca Rocca, Emma Hansson, Milan Milojevic, Anders Jeppsson

16-04-2025

https://doi.org/10.4081/btvb.2025.178

166

PDF: 40
Venous thromboembolism and mortality in patients with hematological malignancies

Kristen M. Sanfilippo, Tzu-Fei Wang

16-05-2024

https://doi.org/10.4081/btvb.2024.119

656

PDF: 232
Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?

Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo

03-08-2023

https://doi.org/10.4081/btvb.2023.90

1358

PDF: 454
Clonal hematopoiesis and inflammation: a link with thrombosis and malignancy

Tiziano Barbui

21-07-2022

https://doi.org/10.4081/btvb.2022.38

2883

PDF: 303
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz

16-05-2024

https://doi.org/10.4081/btvb.2024.118

763

PDF: 299
Cancer-associated ischemic stroke: current knowledge and future directions

Ronda Lun, Deborah M. Siegal

16-05-2024

https://doi.org/10.4081/btvb.2024.117

1792

PDF: 456
The clinical usefulness of measuring thrombin generation

Coenraad H. Hemker

06-03-2023

https://doi.org/10.4081/btvb.2023.62

810

PDF: 361
Venous thromboembolism prophylaxis in orthopedic surgery: a narrative review

Sarah Gallitto, Thomas C. Varkey, Jacob Lahti

13-12-2024

https://doi.org/10.4081/btvb.2024.131

1062

PDF: 169
A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice

Stefania Momi, Giuseppe Guglielmini, Giulia Ciarroca Taranta, Elisa Giglio, Angela Monopoli, Paolo Gresele

23-05-2022

https://doi.org/10.4081/btvb.2022.19

4640

PDF: 263
Endothelial cell dysfunction in cancer: a not-so-innocent bystander

Betül Ünlü, Neha Joshi, Jamie M. O'Sullivan

16-05-2024

https://doi.org/10.4081/btvb.2024.116

1236

PDF: 235
“Living under the sword of Damocles”: a psychological support project for patients with immune thrombocytopenia and their caregivers

Giuseppe Auteri, Laura Ricci, Nicola Vianelli, Barbara Lovrencic

13-03-2025

https://doi.org/10.4081/btvb.2025.161

291

PDF: 118

Appendix A: 31

Appendix B: 37

1 - 42 of 42 items

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy